Coptidis rhizoma and berberine as anti-cancer drugs: A 10-year updates and future perspectives

被引：1
作者：
Chen, Guoming [1 ]
Zhang, Cheng [1 ]
Zou, Jiayi [2 ]
Zhou, Zitian [3 ]
Zhang, Jiayi [2 ]
Yan, Ying [4 ]
Liang, Yinglan [5 ]
Tang, Guoyi [1 ]
Chen, Guang [1 ]
Xu, Xiaoyu [1 ]
Wang, Ning [1 ]
Feng, Yibin [1 ]
机构：
[1] Univ Hong Kong, Sch Chinese Med, Hong Kong, Peoples R China
[2] Guangzhou Univ Chinese Med, Sch Clin Med 1, Guangzhou, Peoples R China
[3] Guangzhou Univ Chinese Med, Sch Clin Med 4, Guangzhou, Peoples R China
[4] Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou, Peoples R China
[5] Guangzhou Univ Chinese Med, Sch Clin Med 2, Guangzhou, Peoples R China
来源：
PHARMACOLOGICAL RESEARCH | 2025年 / 216卷
关键词：
Coptidis Rhizoma; Berberine; Anti-cancer; ESOPHAGEAL CANCER-CELL; BREAST-CANCER; ANTITUMOR-ACTIVITY; LIVER-CANCER; LUNG-CANCER; KAPPA-B; PROLIFERATION; INHIBITION; APOPTOSIS; RESISTANCE;
D O I：
10.1016/j.phrs.2025.107742
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Cancer continues to be among the most substantial health challenges globally. Among various natural compounds, berberine, an isoquinoline alkaloid obtained from Coptidis Rhizoma, has garnered considerable attention for its broad-spectrum biological activities, including anti-inflammatory, antioxidant, anti-diabetic, antiobesity, and anti-microbial activities. Furthermore, berberine exhibits a broad spectrum of anti-cancer efficacy against various malignancies, such as ovarian, breast, lung, gastric, hepatic, colorectal, cervical, and prostate cancers. Its anti-cancer mechanisms are multifaceted, encompassing the inhibition of cancer cell proliferation, the prevention of metastasis, the induction of apoptosis, the facilitation of autophagy, the modulation of the tumor microenvironment and gut microbiota, and the enhancement of the efficacy of conventional therapeutic strategies. This paper offers an exhaustive overview of the cancer-fighting characteristics of Coptidis Rhizoma and berberine, while also exploring recent developments in nanotechnology aimed at enhancing the bioavailability of berberine. Furthermore, the side effects and safety of berberine are addressed as well. The potential role of artificial intelligence in optimizing berberine's therapeutic applications is also highlighted. This paper provides precious perspectives on the prospective application of Coptidis Rhizoma and berberine in the prevention and management of cancer.
引用
收藏
页数：19
相关论文
共 246 条
[1]  
Akula Shaw M., 2019, Advances in Biological Regulation, V73, P100633, DOI 10.1016/j.jbior.2019.04.003
[2]   Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy [J].
Bader, Jackie E. ;
Voss, Kelsey ;
Rathmell, Jeffrey C. .
MOLECULAR CELL, 2020, 78 (06) :1019-1033
[3]  
Bin G.Z., 2019, Shizhen, a Chin. Med. Pract., Spec. Chin. Med., V30, P1532
[4]   Berberine: An inspiring resource for the treatment of colorectal diseases [J].
Cao, Fang ;
Xia, Weiyang ;
Dai, Shengcheng ;
Wang, Changkang ;
Shi, Rui ;
Yang, Yujie ;
Guo, Cui ;
Xu, Xue liang ;
Luo, Jian .
BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
[5]   Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC [J].
Chan, Yau-Tuen ;
Wu, Junyu ;
Lu, Yuanjun ;
Li, Qiucheng ;
Feng, Zixin ;
Xu, Lin ;
Yuan, Hongchao ;
Xing, Tingyuan ;
Zhang, Cheng ;
Tan, Hor-Yue ;
Feng, Yibin ;
Wang, Ning .
MOLECULAR CANCER, 2024, 23 (01)
[6]   Inhibitory effects of Zuo-Jin-Wan and its alkaloidal ingredients on activator protein 1, nuclear factor-κB, and cellular transformation in HepG2 cells [J].
Chao, De-Cheng ;
Lin, Li-Jen ;
Kao, Shung-Te ;
Huang, Hui-Chi ;
Chang, Chih-Shiang ;
Liang, Ji-An ;
Wu, Shih-Lu ;
Hsiang, Chien-Yun ;
Ho, Tin-Yun .
FITOTERAPIA, 2011, 82 (04) :696-703
[7]   Small-molecule in cancer immunotherapy: Revolutionizing cancer treatment with transformative, game-changing breakthroughs [J].
Chattopadhyay, Soumyadeep ;
Hazra, Rudradeep ;
Mallick, Arijit ;
Gayen, Sakuntala ;
Roy, Souvik .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (05)
[8]  
[陈春苗 Chen Chunmiao], 2020, [中国药理学通报, Chinese Pharmacological Bulletin], V36, P261
[9]   Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota- mediated lysophosphatidylcholine [J].
Chen, Haitao ;
Ye, Chenxiao ;
Wu, Changhong ;
Zhang, Jiali ;
Xu, Lu ;
Wang, Xuanying ;
Xu, Chao ;
Zhang, Jin ;
Guo, Yong ;
Yao, Qinghua .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (07) :2097-2113
[10]   Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota [J].
Chen, Haitao ;
Ye, Chenxiao ;
Cai, Biyu ;
Zhang, Fan ;
Wang, Xuanying ;
Zhang, Jin ;
Zhang, Zewei ;
Guo, Yong ;
Yao, Qinghua .
BMC CANCER, 2022, 22 (01)
12345678910